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1. Introduction 
Protein-protein interactions (PPI), in which, two or more proteins associate with each other 
by various means, are key to understanding all biological processes that occur within as well 
as between cells. In effect, biological processes are essentially interactions between multiple 
proteins (Zhang et al., 2011) with PPI networks controlling the flow of information both 
within and between biological processes. 
Disruptions in PPI networks have been shown to result in diseases. This includes monogenic 
diseases such as hemophilia where a particular biochemical pathway is disrupted, as well as 
more complex diseases such as cancer, which involve several signaling pathways (Sam et al., 
2007). Conversely, disruption of a set of PPI can lead to a particular disease or, in the case 
where the set is shared among several networks, to several diseases. While there is a wealth 
of protein-disease associations in the published literature that have been incorporated in PPI 
repositories, the challenge is to link such PPI to human disease (Ideker & Sharan, 2008). 
In this chapter we discuss several examples of diseases that are caused by disruptions of PPI 
networks. Our goal is to illustrate through examples how the role of PPI in disease can be 
studied using a variety of computational tools and data sources. While we discuss tools and 
data sources that are of general interest, we also discuss methods for studying specific 
diseases and methods aimed at large scale analysis of PPI data to identify classes of diseases. 
In each case we provide specific examples from the literature and a brief discussion of the 
tools used. 
2. PPI and disease example 
Let us consider cerebral malaria as an example to understand how an analysis of PPI could 
be used to elucidate the molecular basis of disease. Here, a wide range of experimental and 
predicted human–Plasmodium (host-parasite), human-human (host-host) and Plasmodium-
Plasmodium (parasite-parasite) PPI are combined and analyzed in the context of key events 
and processes of cerebral malaria, a dangerous infectious disease (Rao et al., 2010). 
Cerebral malaria is a severe form of malarial infection, characterized by cerebral 
complications, such as neuronal damage and coma (Moxon et al., 2009). The disease is 
characterized by processes such as sequestration of infected red blood cells to cerebral 
capillaries and venules, systemic inflammation, hemostasis dysfunction and neuronal 
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damage (van der Heyde et al., 2006; Wilson et al., 2008). PPI datasets from different sources 
were first obtained, summarized in Table 1. Since each dataset uses a different nomenclature 
system for the human and parasite proteins, a crucial step was to normalize all datasets 
using common gene names. This enabled creation of a unified host-parasite PPI dataset. 
 
No Source Reference 
1 Davis dataset Davis et al., 2007 
2 Dyer dataset Dyer et al., 2007 
3 Krishnadev dataset Krishnadev & Srinivasan, 2008 
4 Vignali dataset Vignali et al., 2008 
5 Literature PPI data  In-house manual curation 
Table 1. Protein-Protein interaction datasets used in the cerebral malaria example. 
An automated literature retrieval module was developed using Entrez Programming Utilities 
(Sayers et al., 2010) to retrieve the list of full-text articles relevant to the malarial parasite. This 
article set was pruned using the Medical Subject Headings (MeSH) controlled vocabulary for 
articles relevant to cerebral malaria. The resultant set was augmented by articles retrieved 
from the Google Scholar database using appropriate disease-specific query terms such as 
systemic inflammation, hemostasis dysfunction etc. This article corpus had two main uses: 
• For extracting biochemical and signaling events of relevance in cerebral malaria. 
• Identifying pairs of interacting proteins within the host, within the parasite and 
between host and parasite. 
Gene Ontology (GO) cellular component annotations from PlasmoDB (Aurrecoechea et al., 
2009), a comprehensive Plasmodium resource, were used to prune the unified PPI dataset 
using the approach of Mahdavi & Lin (2007). In the case of PPI involving parasite proteins, 
only those proteins that were annotated to be present on the parasite surface or were 
reported to be released during the relevant stage of the parasite were considered (Lyon et 
al., 1986). For the human protein annotations, tissue-specific annotations from UniProt 
(Hubbard et al., 2009) were used in the pruning process. 
The resultant PPI subset was then analyzed by mapping the PPI to key events that influence 
the processes of the disease, as identified from the key review articles. The analysis showed 
the potential significance of apolipoproteins and heat-shock proteins on efficient Plasmodium 
falciparum erythrocyte membrane protein 1 (PfEMP1) presentation, role of the merozoite 
surface protein (MSP-1) in platelet activation, the role of albumin in astrocyte dysfunction 
and the effect of parasite proteins in transforming growth factor (TGF)-β regulation. The 
linking of these PPI to molecular events associated with the disease pathogenesis provides a 
basis for further experiments to determine the molecular basis of this fatal disease. 
3. Tools of the trade 
From the example, it is clear that the underpinnings for mapping PPI to disease are: (a) 
access to various repositories of PPI and (b) ability to filter these PPI in the context of disease 
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and (c) using different tools for visualizing and analyzing the PPI in the context of diseases. 
Let us consider each of these in detail. 
3.1 PPI repositories 
There are a host of repositories that house experimental and predicted PPI data. The cerebral 
malaria example above considered malaria-specific PPI datasets. However, generic datasets 
such as BIND, DIP, HPRD, MINT, MIPS and STRING usually have the necessary PPI 
coverage required for a variety of disease studies. 
The Biomolecular Interaction Network Database (BIND), a constituent database of the 
Biomolecular Object Network Databank, makes available a comprehensive collection of 
information for specific molecules such as proteins and small molecules (Bader et al., 2003). 
BIND has been one of the major sources of curated biomolecular interactions, especially PPI. 
The Database of Interacting Proteins (DIP) contains experimentally determined PPI 
(Salwinski et al., 2004). It has been created using both manual curation and computational 
approaches. The Human Protein Reference Database (HPRD) provides a platform to 
visually depict and integrate information, which are manually curated, pertaining to 
domain architecture, post-translational modifications, PPI networks and disease association 
for each protein of the human proteome (Prasad et al., 2009).  
The Molecular INTeraction database (MINT) contains experimentally verified PPI that have 
been manually curated from the scientific literature (Ceol et al., 2010). The Mammalian 
Protein-Protein Interaction (MIPS) database is a collection of manually curated high-quality 
PPI data collected from the scientific literature by expert curators (Pagel et al., 2005). 
STRING is a database of known and predicted protein interactions (Szklarczyk et al., 2011). 
The interactions include direct (physical) as well as indirect (functional) associations. 
Composite PPI resources are also available that integrate PPI data from some of these 
databases into a single resource. APID (Agile Protein Interaction DataAnalyzer), for instance, 
is one such resource that integrates experimentally validated PPI from databases such as 
BIND, DIP, HPRD and MINT, amongst others (Prieto et al., 2006). Protein Interaction Network 
Analysis (PINA) platform is another example of a composite PPI resource that integrates 
interactions from MINT, DIP, HPRD and MIPS, amongst others (Wu et al., 2009). 
3.2 Integration and filtering of PPI 
Databases and tools such as Reactome, GO, MeSH and the Entrez Programming Utilities are 
crucial for filtering the large number of PPI to obtain a PPI network relevant to a specific 
disease. 
Reactome is a database of biological pathways from various organisms, especially humans 
(Matthews et al., 2009). This is manually curated by experts. It contains various entities such 
as proteins, chemicals, localization data, etc. The information in Reactome is cross-
referenced to various standard bioinformatics databases such as Entrez Gene, UniProt, 
Ensembl, etc. The GO project attempts to standardize the description of gene and gene 
products across species and databases (The Gene Ontology Consortium, 2000). It consists of 
three ontologies that describe genes and gene products in relation to biological processes, 
molecular functions and cellular components. 
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MeSH (http://www.nlm.nih.gov/mesh/) is a controlled vocabulary thesaurus maintained 
by the National Library of Medicine. It is made up of terms naming descriptors in a 
hierarchical structure that permits searching at various levels of specificity. It currently has 
16 major tree headings including "Diseases" and “Chemicals and Drugs”. MeSH terms are 
used in various methods and tools to filter articles/abstracts and other data. Online 
Mendelian Inheritance in Man (OMIM) is a database of known Mendelian disorders and 
their related genes (Hamosh et al., 2002). Currently, there are around 12,000 genes described 
in this database. OMIM provides information on genotype-phenotype relationships in 
human Mendelian diseases. 
Specific tools are available to access some of these databases, such as the Entrez 
Programming Utilities (Sayers et al., 2010). These are a set of server-side programs enabling 
a stable interface to utilize the Entrez query and database system at the National Center for 
Biotechnology Information. There are currently 38 databases in the Entrez system with a 
wide variety of information on nucleotide and protein structure and sequences, 3D-
molecular structures, disease information and biomedical literature etc. 
3.3 Visualization tools 
Important tools that could aid in mapping PPI to disease include: 
• Cytoscape (Shannon et al., 2003) for visualizing PPI datasets with nodes representing 
biological entities and edges representing the relationships between these entities 
• Cell Circuits (Mak et al., 2007) for comparison of hand-curated pathway models to 
hypothetical models derived from large-scale 'omic' data. 
Cytoscape plugins such as APID2NET (Hernandez-Toro et al., 2007) and PRINCIPLE 
(Gottlieb et al., 2011) are also very pertinent. APID2NET retrieves PPI data from the APID 
server for further analysis within the Cytoscape environment. PRINCIPLE, discussed later 
in this chapter, is built specifically for exploring PPI-disease associations. Given any disease 
as a query term, it provides a list of top-ranking genes associated with this disease and a 
Cytoscape visualization of the sub-networks formed by these genes and their direct 
interacting neighbors. 
IPA (Ingenuity Systems, www.ingenuity.com) is an example of a commercially available 
platform that enables visualization of dynamically constructed pathway and network 
models. 
4. PPI from literature 
What happens when the PPI repositories do not have adequate coverage of the organism or 
specific protein-set under study? One possibility is that although such repositories do not 
have these PPI, the PPI have actually been reported in literature. One just needs to go look 
for them! 
Let us consider an example of using text-mining to extract such PPI. In the cerebral 
malaria study, a basic text-mining approach has been used (Rao et. al., 2010). The article 
corpus was first checked for article-level co-occurrence of pairs of proteins. Full-text 
articles, wherever available, are automatically downloaded from the respective journal 
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websites as Portable Document Format (PDF) files and converted to text format using the 
XPDF conversion utility (The FooLabs, http://www.foolabs.com/xpdf). All parasite and 
host proteins that occur in the full-text of each article were identified using a dictionary 
lookup approach, with PlasmoDB and UniProt/Ensembl being used to create the parasite 
and human protein dictionaries respectively. Only those articles that had at least one 
protein pair (host-parasite, host-host or parasite-parasite) were considered for further 
analysis. 
Özgür et al. (2008) propose a more detailed approach based on integrating automatic text 
mining and network analysis methods to extract known disease genes and to predict 
unknown disease genes. They started by collecting an initial set of seed genes known to be 
related to a disease from curated databases such as OMIM. A disease specific gene network 
was created using advanced natural language processing techniques that capture both gene 
names as well as the semantic associations between them. 
5. PPI Networks and SNPs 
Genome-wide measurement technologies such as microarrays have provided an 
opportunity to identify genes that are mutated or differentially expressed. In particular, 
SNP-arrays have been very useful in such studies and have resulted in identification of 
several genes that are associated with disease-risk or poor prognosis (Karinen et al., 2011). 
Such genes typically affect cellular functions by altering signaling in regulatory PPI 
networks. 
The mainstay of this approach is the fact that genes related to the same disease are also 
known to have protein products that physically interact (Navlakha & Kingsford, 2010). 
However, that by itself is only one crucial component. The other important component is 
that a genetic disease is associated with a linkage interval on the chromosome if SNPs in the 
interval are correlated with an increased susceptibility to the disease. These linkage intervals 
define a potential disease-causing gene set. The computational approach boils down to 
using both these sources of information—PPI networks and linkage intervals to predict 
relationships between genes and diseases. 
Let us look at a method called CANGES to identify the genetic basis of disease (Karinen et 
al., 2011). The strength of the method lies in its ability to cohesively integrate many 
different pieces of information to arrive at testable hypotheses. Genome wide association 
studies have identified many variations that are possibly linked to one or more diseases. 
How does one go about prioritizing these variations to get to a set of genes that cause the 
disease? Clearly, one needs to bring in other known information to help arrive at a 
decision. The CANGES method combines pathway data, PPI data and genetic variation 
data with analytical tools to rapidly evaluate the disease causing potential of variations 
and thus focus attention on one or a few genes. Using this method, a set of 158 SNPs in 
the p53 gene were identified that plays a central role in cancers. These SNPs are likely to 
have pathogenic consequences. The same method has also been used, in conjunction with 
clinical patient data, to identify genes associated with glioblastoma multiforme. It is clear 
that in the future we will see many more such methods which bring together PPI with 
several other pieces of information and analytical tools to identify disease genes and gene 
networks. 
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Several computational methods can be used to identify causal genes central to gene-disease 
relationships from large PPI networks. The methods include network neighbors and 
neighborhood methods, unsupervised graph partitioning and Markov clustering, semi-
supervised graph partitioning, random walks, network flow methods and several of their 
variants (Navlakha & Kingsford, 2010). Navlakha & Kingsford tested these on two large PPI 
networks: (a) one derived from the Human Protein Reference Database, consisting of 8776 
proteins and 35,820 PPI and (b) the other derived from Online Predicted Human Interaction 
Database containing 9842 proteins and 73130 PPI. Annotations from OMIM were used to 
associate diseases with genes and linkage intervals. They observed that the performance of 
most methods showed a significant correlation with neighborhood homophily. Based on 
this, they suggest that homophily could be used to assess the quality of network-based 
predictions of disease-protein relationships. They also observed that the individual methods 
capture different kinds of structure in the network and these unique abilities can be used 
together in a consensus method to enhance prediction quality. 
6. Structural significance of PPI 
One important disease class in which a study of PPI could shed light is cancer. Let us look at 
a study that analyzed cancer proteins in human PPI networks (Kar et al., 2009). This study is 
important from a methodology perspective as it uses structural properties of the proteins 
present in the PPI network. Integrating three-dimensional protein structural information 
into PPI networks revealed important aspects about cancer-related proteins. Analysis of the 
structural properties of cancer-related interface proteins showed that the interfaces are, on 
an average, smaller in size, more planar, less tightly packed and more hydrophilic than 
those of non-cancer proteins. For instance, in a breast cancer network used in the study, 
there was significant accuracy in discriminating cancer-protein interfaces from the non-
cancer interfaces. Thus, there seems to be a clear distinction between the interfaces. 
In addition, they observed that cancer-related proteins tend to interact with their partners 
via multi-interface hubs, which comprise 56% of cancer-related proteins. Cancer protein 
networks are therefore more enriched in multi-interface proteins. Cancer proteins, in 
general, are longer and have larger surface areas. Thus, to participate in many PPI at the 
same time, these tend to be multi-interface hubs, with distinct interfaces interacting with 
different proteins. 
The processes involved in obtaining relevant PPI with regard to a disease are shown in 
Figure 1. 
7. PPI common across diseases 
The hitherto discussed examples link diseases with their possible proteomic underpinnings. 
Research is also underway that focuses on bridging the gap between PPI and their 
association to different diseases. The goal is to bring out underlying PPI that are common 
amongst different sets of diseases. Diseases with overlapping clinical phenotypes are caused 
by mutations in functionally related genes. Since PPI are the strongest manifestation of a 
functional relationship between disease genes, applying a network model is an effective 
approach for revealing the associations among diseases (Zhang et al., 2011). 
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Fig. 1. Processes involved in obtaining relevant PPI with regard to a disease. 
7.1 Background 
Traditionally, diseases are defined as ‘similar’ mainly by their clinical appearance, with no 
correlation to underlying molecular processes. Conceptually, each monogenic disease has a 
collection of specific phenotypic features. This is true for about 2000 human single gene 
diseases with a defined genetic phenotype. Syndromes are defined in medicine as a set of 
phenotypes which, occurring together, serve to define a trait or disease. However, 
phenotypes very often overlap in the case of many syndromes. Recognition of this overlap 
brought about the concept of ‘syndrome families’ taking into account the common features 
shared between diseases (Sam et al., 2007). 
The clustering of syndromes into these families in combination with genetic insights has led 
to the discovery that what were often thought as two different disorders were really variable 
expressions of the same disorder. On the other hand, it has long been known that mutations 
at different loci can lead to the same genetic disease. It has also been hypothesized that this 
genetic heterogeneity has its roots at the PPI level, suggesting that other genes associated 
with the phenotype also have some functional role. Therefore, it is plausible that functional 
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properties of shared molecular networks reflect phenotypic overlap of diseases. Thus, PPI 
networks provide unique opportunities for exploring disease pathways (Sam et al., 2007). 
Let us continue with cancer as a disease theme. Sam et al. (2007) highlight an example that 
links Fanconi’s Anemia and cancer. Fanconi’s Anemia is a hereditary DNA-repair deficiency 
disease characterized by defects in a set of DNA repair proteins, leading to, among others, 
hypersensitivity to DNA damaging agents. This disorder is caused by a mutation in any one 
of the genes in Fanconi’s Anemia complementation group. Symptoms of the disease include 
anemia, several congenital malformations, etc. Importantly, patients suffering from it exhibit 
a strong predisposition to different cancers. In the study, this link was substantiated with 14 
potential PPI common between Fanconi’s Anemia and colorectal neoplasms. 
7.2 PPI and common phenotypes 
Let us consider another example where a PPI network has been systematically combined 
with disease-protein relationship data derived from mining GO annotations with 
phenotypic context (Sam et al., 2007). PPI associated with pairs of diseases were identified 
and the statistical significance of the occurrence of interactions in the protein interaction 
knowledgebase calculated. This study demonstrates that the associations between diseases 
are directly correlated to their underlying PPI networks. A subset of PhenoGO (Lussier et 
al., 2006; Sam et al., 2009) restricted to human diseases was examined to study the 
relationships between diseases according to the following criteria. Two basic types of 
relationships were considered, which determine whether two diseases share PPI networks: 
a) an identity relationship where common proteins are shared by two diseases, and b) direct 
interactions between protein A of one disease and protein B of another. A total of 10 pairs of 
diseases were identified that are significantly correlated due to their shared proteins and 
PPI. These pairs were analyzed based on mentions in literature, and their correlations were 
confirmed. 
Xeroderma pigmentosum and Cockayne syndrome provide an example of how two diseases 
are correlated through their PPI networks. Xeroderma pigmentosum is a disorder causing 
susceptibility of the skin to ultraviolet radiation as a result of deficiencies in one of the XPA-
XPG complementation group genes involved in nucleotide excision repair (NER). Cockayne 
syndrome results from deficiencies in transcription-coupled repair genes, like ERCC6 and 
ERCC8, leading to a number of conditions including abnormal sensitivity to sunlight (Sam 
et al., 2007; Spivak et al., 2004). There were 27 direct PPI and 5 common proteins shared 
amongst these two diseases. Majority of the proteins in the common networks between the 
two diseases are related to DNA repair processes - Global Genomic NER and Transcription-
coupled NER. While the Global Genomic NER repairs lesions from non-transcribed regions 
of genome independent to transcription, the Transcription-coupled NER repairs UV 
induced damage in the transcribed strands of active genes. Both the diseases are seen to be 
associated with these processes, suggesting defects in the DNA damage repair processes are 
the cause of the diseases. 
7.3 Of PRINCE and PRINCIPLEs 
PRINCIPLE is very relevant tool specifically built for finding out common diseases based on 
PPI. It is a Cytoscape plugin implementation of the PRINCE algorithm (Vanunu, et al., 
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2010). Given a query disease, it provides a list of top ranking genes associated with it and an 
additional visualization of the sub-networks formed by these top ranking genes and their 
direct interacting neighbors. The underlying logic is that genes causing similar diseases 
often lie close to one another in a PPI network (Oti & Brunner, 2007; Oti, et al., 2006). Given 
a disease as the query term, PRINCE (a) identifies a set of phenotypically similar diseases, 
(b) retrieves the known causal genes of these diseases based on their similarity to the query 
and (c) propagates the scores of the prior set of genes over a human PPI network to provide 
association scores for all genes. It uses a comprehensive set of weighted PPI compiled from 
disparate sources (Vanunu, et al., 2010), disease-disease similarity measures (van Driel, et 
al., 2006), and on the disease-gene associations present in OMIM. 
7.4 Human disease network – The holy grail! 
Zhang et al. (2011) constructed an expanded Human Disease Network by combining 
disease-gene information with PPI information. Work such as this is very important, since a 
network model to represent relationships between diseases is very useful in looking at 
relationships amongst diseases on a large scale. Analysis of the network's topological 
features and functional properties showed that the network was hierarchical. Most diseases 
in the network were connected to only a few diseases, while a small set of diseases were 
linked to many different diseases. Also, diseases in a specific disease category tended to 
cluster together, and genes associated with the same disease were functionally related. 
While this might intuitively sound obvious, it establishes a molecular basis for disease-
disease associations.  
The limitation of the network is that only known and available disease phenotypic data has 
been incorporated. However, as more data is made available in databases and in literature, 
this network provides an ideal template to analyze relationships amongst diseases from a 
PPI perspective. 
8. The road ahead 
This is a new field and there are many more approaches than what has been brought out in 
this chapter. For instance, Bandyopadhyay et al. (2006) use a network analysis of gene 
expression and PPI data to identify active pathways related to HIV pathogenesis. A 
functional analysis of the detected sub-networks provides useful insights into various stages 
of the HIV replication cycle. Chen et al. (2006) developed a framework to mine disease-
related proteins from OMIM and PPI data. They demonstrate the power of their method by 
applying it to Alzheimer’s disease. The key to their method is a scoring function that ranks 
proteins according to their relevance to a particular disease pathway. 
Methods to arrive at high-precision predictions that are translatable to effective steps in 
disease prevention, diagnosis and prognosis should be the goal of PPI studies. The 
generated leads should be tested experimentally to determine their relevance. 
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